Iszkémia/reperfúzió indukálta károsodások farmakológiai befolyásolási lehetőségei

A tétel rövid nézete
dc.contributor.advisorTósaki, Árpád
dc.contributor.authorBak, István
dc.contributor.departmentDE -- Orvos- és Egészségtudományi Centrum -- Gyógyszerésztudományi Kar -- Gyógyszerhatástani Tanszéken
dc.contributor.departmentGyógyszertudományok doktori iskolahu
dc.date.accessioned2006-12-19T10:26:44Z
dc.date.available2006-12-19T10:26:44Z
dc.date.created2003
dc.date.defended2003-03-28
dc.date.issued2006-12-19T10:26:44Z
dc.description.abstractCardiac ischemia/reperfusion is among the most common causes of morbidity and mortality. Decreased oxygen supply and perfusion can cause serious injuries. The overall aims of our studies were to investigate pharmacological approaches capable of reducing ischemia/reperfusion induced damage. In the first part of our experiments we examined the effect of the combined treatment of FK506 (tacrolimus) and EGb 761 (standardized Ginkgo biloba extract). Our results suggest that the combination of these drugs significantly reduces arrhythmias and improves postischemic heart function. The combined therapy could enable to use FK506 in subtoxical doses. This suggests that pharmaceutical interventions incorporating both classes of drug may provide a new and powerful approach to management of ischemic injury associated with heart disease and surgical intervention. It is a general clinical process to use NO in treatment of ischemic heart diseases. Henceforth in the second part of our experiment we studied the role of an other gaseous endogenous monoxide, carbon monoxide, produced by heme oxygenase in prevention of reperfusion induced arrhythmias. Our results indicate that production of endogenous CO significantly decreased in hearts developed ventricular fibrillation. In hearts perfused with PBN, a significant increase in endogenous CO production via the HO-1 mRNA expression was observed, and with the elevation of endogenous CO production, the development of VF was not recorded during reperfusion. Thus, our findings suggest that pharmacological stimulation of the expression of HO-1 could prevent the development of reperfusion-induced arrhythmias. Our last experiments were planed to reveal the way of inhibition of ischemia/reperfusion induced apoptosis. A number of cascade mechanisms have been identified in the induction or inhibition of apoptosis but caspases play a crucial role in this process. Drugs capable of influencing apoptosis are of great importance concerning therapeutic treatment. The most useful method for inhibition of apoptosis could be the inhibition of its universal effectors: the caspases. Both our results and publications of other groups suggest that caspase inhibitors may function as potent agents in treatment of acut ischemic diseases, although it must be noted that apoptosis occurs continuously and almost in all of our organs consequently general inhibition of apoptosis may cause serious clinical injuries.en
dc.description.correctorNE
dc.description.degreePhDen
dc.format.extent54 pen
dc.format.extent362648 bytes
dc.format.extent257007 bytes
dc.format.extent987644 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.identifier.opachttp://webpac.lib.unideb.hu:8082/WebPac/CorvinaWeb?action=cclfind&resultview=longlong&ccltext=idno+bibKLT00386431
dc.identifier.urihttp://hdl.handle.net/2437/444
dc.languagehunhu
dc.language.isohuen
dc.language.isoenen
dc.rightsno_restrictionen
dc.subject.disciplineGyógyszertudományokhu
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu
dc.subject.dspaceDEENK Témalista::Orvostudomány::Kardiológiahu
dc.subject.meshIschemiaen
dc.subject.meshMyocardial Reperfusion Injury -- prevention and controlen
dc.subject.meshMyocardial Reperfusion Injury -- drug therapyen
dc.subject.meshOxidative Stressen
dc.subject.meshGinkgo bilobaen
dc.subject.meshTacrolimusen
dc.subject.meshCaspasesen
dc.subject.meshHeme Oxigenase-1en
dc.subject.meshCarbon Monoxideen
dc.subject.sciencefieldOrvostudományokhu
dc.titleIszkémia/reperfúzió indukálta károsodások farmakológiai befolyásolási lehetőségeien
dc.title.subtitledoktori (Ph.D.) értekezésen
dc.title.translatedIschemia / Reperfusion Induced - Injury: Control and Mechanisms in the Myocardiumen
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 3 (Összesen 3)
Nem elérhető
Név:
Bak_Istvan_ertekezes.pdf
Méret:
964.5 KB
Formátum:
Adobe Portable Document Format
Leírás:
értekezés
Letöltés
Nem elérhető
Név:
Bak_Istvan_tezis_angol.pdf
Méret:
250.98 KB
Formátum:
Adobe Portable Document Format
Leírás:
tézis angol
Letöltés
Nem elérhető
Név:
Bak_Istvan_tezis_magyar.pdf
Méret:
354.15 KB
Formátum:
Adobe Portable Document Format
Leírás:
tézis magyar
Letöltés
Gyűjtemények
Gyógyszerészeti Tudományok Doktori Iskola